{
    "nctId": "NCT00251095",
    "briefTitle": "Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer",
    "officialTitle": "A Multicenter Phase 3, Randomized Comparison of the Safety and Efficacy of Weekly TOCOSOL(R) Paclitaxel vs. Weekly Paclitaxel Injection in the Treatment of Metastatic Breast Cancer",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Neoplasm",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 821,
    "primaryOutcomeMeasure": "Objective response rates",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with histologic diagnosis of breast carcinoma\n* Stage IV (M1) disease\n* Adult (18 years of age or older) patients\n\nExclusion Criteria:\n\n* Patients treated with a taxane within the past year\n* Patients whose tumor tissue is known to show over expression of HER2/neu",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}